Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis

Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis

Бусад хувилбаруудыг харуулах (2)

Background: Evaluating the long term benefit of therapy in multiple sclerosis (MS) is challenging. Although randomised controlled trials (RCTs) demonstrate therapeutic benefits on short term outcomes, the relationship between these outcomes and late disability is not established. Methods: In a patie...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Goodin, D, Traboulsee, A, Knappertz, V, Reder, A, Li, D, Langdon, D, Wolf, C, Beckmann, K, Konieczny, A, Ebers, G
Формат:	Journal article
Хэвлэсэн:	2012

Ижил төстэй зүйлс

Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis
-н: Goodin, D, зэрэг
Хэвлэсэн: (2012)

Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis.
-н: Goodin, D, зэрэг
Хэвлэсэн: (2012)

Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFNβ-1b trial.
-н: Goodin, D, зэрэг
Хэвлэсэн: (2012)

Cause of death in MS: long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study
-н: Goodin, D, зэрэг
Хэвлэсэн: (2012)

Long-term follow-up of the original interferon-beta1b trial in multiple sclerosis: design and lessons from a 16-year observational study.
-н: Ebers, G, зэрэг
Хэвлэсэн: (2009)

Mortality in patients with multiple sclerosis.
-н: Scalfari, A, зэрэг
Хэвлэсэн: (2013)

Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial.
-н: Ebers, G, зэрэг
Хэвлэсэн: (2010)

CAUSE OF DEATH IN MULTIPLE SCLEROSIS PATIENTS FROM THE 21-YEAR LONG-TERM FOLLOW-UP STUDY
-н: Ebers, G, зэрэг
Хэвлэсэн: (2011)

The final results of the interferon beta-1b 16-year long-term follow-up study
-н: Ebers, G, зэрэг
Хэвлэсэн: (2006)

The interferon beta-1b 16-year long-term follow-up study: Neutralizing antibodies and clinical outcomes
-н: Reder, A, зэрэг
Хэвлэсэн: (2008)

Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing-remitting MS.
-н: Reder, A, зэрэг
Хэвлэсэн: (2010)

EDSS and MRI burden of disease predict cognitive status at 16 years: data from the long term follow-up study
-н: Langdon, D, зэрэг
Хэвлэсэн: (2007)

Establishing long-term efficacy in chronic disease: use of recursive partitioning and propensity score adjustment to estimate outcome in MS.
-н: Douglas S Goodin, зэрэг
Хэвлэсэн: (2011-01-01)

16-year long-term follow-up of interferon beta-1b treatment in patients with multiple sclerosis
-н: Ebers, G, зэрэг
Хэвлэсэн: (2005)

Long-term follow up of interferon-beta-1b pivotal trial RRMS patients: design issues of a 16-year follow-up study
-н: Ebers, G, зэрэг
Хэвлэсэн: (2004)

Causes of death among commercially insured multiple sclerosis patients in the United States.
-н: Douglas S Goodin, зэрэг
Хэвлэсэн: (2014-01-01)

Treatment of multiple sclerosis with interferon beta-1b - Reply
-н: Sibley, W, зэрэг
Хэвлэсэн: (1997)

INTERFERON-BETA TREATMENT OF MULTIPLE-SCLEROSIS - REPLY
-н: Sibley, W, зэрэг
Хэвлэсэн: (1994)

Interferons in relapsing remitting multiple sclerosis.
-н: Goodin, D
Хэвлэсэн: (2003)

Cause of death in MS: Longterm follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study (BMJ Open (2012) 2 (e001972))
-н: Goodin, D, зэрэг
Хэвлэсэн: (2013)

Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis.
-н: Petkau, A, зэрэг
Хэвлэсэн: (2004)

A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosis
-н: Colin J. Ross, зэрэг
Хэвлэсэн: (2017-05-01)

Systemic interferon alfa in multiple sclerosis.
-н: Weinshenker, BG, зэрэг
Хэвлэсэн: (1989)

The multiple sclerosis PRISMS study: Prevention of relapses and disability by interferon beta-1a subcutaneously in multiple sclerosis
-н: Ebers, G, зэрэг
Хэвлэсэн: (1997)

Interferons in relapsing remitting multiple sclerosis - Authors' reply
-н: Filippini, G, зэрэг
Хэвлэсэн: (2003)

Interferons in relapsing remitting multiple sclerosis - Authors' reply
-н: Filippini, G, зэрэг
Хэвлэсэн: (2003)

Age and disability accumulation in multiple sclerosis.
-н: Scalfari, A, зэрэг
Хэвлэсэн: (2011)

Clinical testing for neutralizing antibodies to interferon-β in multiple sclerosis
-н: Paul I. Creeke, зэрэг
Хэвлэсэн: (2013-01-01)

Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.
-н: Ebers, G, зэрэг
Хэвлэсэн: (1998)

Interferons in relapsing remitting multiple sclerosis: a systematic review.
-н: Filippini, G, зэрэг
Хэвлэсэн: (2003)

Interferon-β corrects massive gene dysregulation in multiple sclerosis: Short-term and long-term effects on immune regulation and neuroprotection
-н: Xuan Feng, зэрэг
Хэвлэсэн: (2019-11-01)

The evolution of interferon therapy in multiple sclerosis
-н: O. V. Boyko, зэрэг
Хэвлэсэн: (2023-08-01)

Drug induced liver injury secondary to interferon-beta (IFN-β) in multiple sclerosis
-н: V. Byrnes, зэрэг
Хэвлэсэн: (2006-01-01)

Curcumin as an add-on therapy for multiple sclerosis in patients receiving interferon-beta therapy
-н: A. D. Kukushkina, зэрэг
Хэвлэсэн: (2024-08-01)

Association of smoking with risk of multiple sclerosis: a population-based study.
-н: Ramagopalan, S, зэрэг
Хэвлэсэн: (2013)

Association of smoking with risk of multiple sclerosis: A population-based study
-н: Ramagopalan, S, зэрэг
Хэвлэсэн: (2013)

Adherence to interferon β treatment in Kosovan multiple sclerosis registry
-н: Blerim Myftiu, зэрэг
Хэвлэсэн: (2024-01-01)

EХPERIENCE IN INTERFERON β-1A USE FOR TREATMENT OF MULTIPLE SCLEROSIS IN CHILDREN
-н: L. M. Kuzenkova, зэрэг
Хэвлэсэн: (2013-09-01)

Interferon beta treatment of multiple sclerosis.
-н: Markovitz, D
Хэвлэсэн: (1994)

CLINICALLY ISOLATED SYNDROME IN CHILDREN AND ADOLESCENTS — RISK FACTORS FOR MULTIPLE SCLEROSIS AND PROSPECTS OF USING INTRAMUSCULAR INTERFERON β-1A
-н: O.V. Bykova, зэрэг
Хэвлэсэн: (2010-05-01)